Clonal variation of p53 expression and proliferative phenotype in A253 squamous carcinoma cells

Susan C. Galbraith, John Foley, Yuliya Kats, Alison Moy, Pamela Dann, William J. Burtis, William M. Philbrick, John J. Orloff

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Loss of normal p53 tumor-suppressor gene function is characteristic of the majority of squamous carcinomas. During the course of gene transfer studies in the human squamous carcinoma cell line, A253, which does not express p53 mRNA or protein, we incidentally observed increased levels of p53 expression in up to 20% of clonal cell lines derived from parental A253 cells. p53-expressing A253 cells (A253-p53) were also isolated by dilutional cloning. Nuclear p53 protein was identified by immunohistochemistry in A253- p53 cells in a wild-type pattern, and p53 mRNA (2.5 kb) was demonstrated by northern blot. Mutational analysis of the p53 gene in A253-p53 cells revealed no evidence for mutations in exons 5-9. A253-p53 cells could be distinguished from native A253 cells by prolonged doubling times (2-5 fold) and by a marked reduction of [3H]-thymidine uptake. Whereas A253 cells were unresponsive to the growth-inhibitory effects of TGF-β, EGF-stimulated A253-p53 cells responded to TGF-β with markedly reduced DNA synthetic rates. A253-p53 cells cocultured with A253 demonstrated enhanced cell growth and DNA synthesis rates compared to control A253-p53 cells. Finally, A253-p53 cells show reduced expression of c-fos, fibronectin, thrombospondin and parathyroid hormone-related protein (PTHrP) mRNAs. PTHrP measured by RIA in conditioned medium was ≃300 pM for A253 but undetectable for A253-p53. We conclude that the A253 cell line contains a subpopulation of cells which express high levels of 'wild-type-like' p53 protein. This results in dramatic changes in gene expression and a slower-growing phenotype in vitro.

Original languageEnglish (US)
Pages (from-to)353-361
Number of pages9
JournalOncology Research
Volume8
Issue number9
StatePublished - 1996
Externally publishedYes

Fingerprint

Squamous Cell Carcinoma
Phenotype
Parathyroid Hormone-Related Protein
Cell Line
Messenger RNA
Thrombospondins
DNA
p53 Genes
Conditioned Culture Medium
Growth
Nuclear Proteins
Tumor Suppressor Genes
Fibronectins
Epidermal Growth Factor
Northern Blotting
Thymidine
Organism Cloning
Exons
Proteins
Immunohistochemistry

Keywords

  • A253
  • p53
  • PTHrP
  • squamous carcinoma

ASJC Scopus subject areas

  • Cancer Research

Cite this

Galbraith, S. C., Foley, J., Kats, Y., Moy, A., Dann, P., Burtis, W. J., ... Orloff, J. J. (1996). Clonal variation of p53 expression and proliferative phenotype in A253 squamous carcinoma cells. Oncology Research, 8(9), 353-361.

Clonal variation of p53 expression and proliferative phenotype in A253 squamous carcinoma cells. / Galbraith, Susan C.; Foley, John; Kats, Yuliya; Moy, Alison; Dann, Pamela; Burtis, William J.; Philbrick, William M.; Orloff, John J.

In: Oncology Research, Vol. 8, No. 9, 1996, p. 353-361.

Research output: Contribution to journalArticle

Galbraith, SC, Foley, J, Kats, Y, Moy, A, Dann, P, Burtis, WJ, Philbrick, WM & Orloff, JJ 1996, 'Clonal variation of p53 expression and proliferative phenotype in A253 squamous carcinoma cells', Oncology Research, vol. 8, no. 9, pp. 353-361.
Galbraith, Susan C. ; Foley, John ; Kats, Yuliya ; Moy, Alison ; Dann, Pamela ; Burtis, William J. ; Philbrick, William M. ; Orloff, John J. / Clonal variation of p53 expression and proliferative phenotype in A253 squamous carcinoma cells. In: Oncology Research. 1996 ; Vol. 8, No. 9. pp. 353-361.
@article{f0ca19dcb3674c98a937ddac135a7e16,
title = "Clonal variation of p53 expression and proliferative phenotype in A253 squamous carcinoma cells",
abstract = "Loss of normal p53 tumor-suppressor gene function is characteristic of the majority of squamous carcinomas. During the course of gene transfer studies in the human squamous carcinoma cell line, A253, which does not express p53 mRNA or protein, we incidentally observed increased levels of p53 expression in up to 20{\%} of clonal cell lines derived from parental A253 cells. p53-expressing A253 cells (A253-p53) were also isolated by dilutional cloning. Nuclear p53 protein was identified by immunohistochemistry in A253- p53 cells in a wild-type pattern, and p53 mRNA (2.5 kb) was demonstrated by northern blot. Mutational analysis of the p53 gene in A253-p53 cells revealed no evidence for mutations in exons 5-9. A253-p53 cells could be distinguished from native A253 cells by prolonged doubling times (2-5 fold) and by a marked reduction of [3H]-thymidine uptake. Whereas A253 cells were unresponsive to the growth-inhibitory effects of TGF-β, EGF-stimulated A253-p53 cells responded to TGF-β with markedly reduced DNA synthetic rates. A253-p53 cells cocultured with A253 demonstrated enhanced cell growth and DNA synthesis rates compared to control A253-p53 cells. Finally, A253-p53 cells show reduced expression of c-fos, fibronectin, thrombospondin and parathyroid hormone-related protein (PTHrP) mRNAs. PTHrP measured by RIA in conditioned medium was ≃300 pM for A253 but undetectable for A253-p53. We conclude that the A253 cell line contains a subpopulation of cells which express high levels of 'wild-type-like' p53 protein. This results in dramatic changes in gene expression and a slower-growing phenotype in vitro.",
keywords = "A253, p53, PTHrP, squamous carcinoma",
author = "Galbraith, {Susan C.} and John Foley and Yuliya Kats and Alison Moy and Pamela Dann and Burtis, {William J.} and Philbrick, {William M.} and Orloff, {John J.}",
year = "1996",
language = "English (US)",
volume = "8",
pages = "353--361",
journal = "Oncology Research",
issn = "0965-0407",
publisher = "Cognizant Communication Corporation",
number = "9",

}

TY - JOUR

T1 - Clonal variation of p53 expression and proliferative phenotype in A253 squamous carcinoma cells

AU - Galbraith, Susan C.

AU - Foley, John

AU - Kats, Yuliya

AU - Moy, Alison

AU - Dann, Pamela

AU - Burtis, William J.

AU - Philbrick, William M.

AU - Orloff, John J.

PY - 1996

Y1 - 1996

N2 - Loss of normal p53 tumor-suppressor gene function is characteristic of the majority of squamous carcinomas. During the course of gene transfer studies in the human squamous carcinoma cell line, A253, which does not express p53 mRNA or protein, we incidentally observed increased levels of p53 expression in up to 20% of clonal cell lines derived from parental A253 cells. p53-expressing A253 cells (A253-p53) were also isolated by dilutional cloning. Nuclear p53 protein was identified by immunohistochemistry in A253- p53 cells in a wild-type pattern, and p53 mRNA (2.5 kb) was demonstrated by northern blot. Mutational analysis of the p53 gene in A253-p53 cells revealed no evidence for mutations in exons 5-9. A253-p53 cells could be distinguished from native A253 cells by prolonged doubling times (2-5 fold) and by a marked reduction of [3H]-thymidine uptake. Whereas A253 cells were unresponsive to the growth-inhibitory effects of TGF-β, EGF-stimulated A253-p53 cells responded to TGF-β with markedly reduced DNA synthetic rates. A253-p53 cells cocultured with A253 demonstrated enhanced cell growth and DNA synthesis rates compared to control A253-p53 cells. Finally, A253-p53 cells show reduced expression of c-fos, fibronectin, thrombospondin and parathyroid hormone-related protein (PTHrP) mRNAs. PTHrP measured by RIA in conditioned medium was ≃300 pM for A253 but undetectable for A253-p53. We conclude that the A253 cell line contains a subpopulation of cells which express high levels of 'wild-type-like' p53 protein. This results in dramatic changes in gene expression and a slower-growing phenotype in vitro.

AB - Loss of normal p53 tumor-suppressor gene function is characteristic of the majority of squamous carcinomas. During the course of gene transfer studies in the human squamous carcinoma cell line, A253, which does not express p53 mRNA or protein, we incidentally observed increased levels of p53 expression in up to 20% of clonal cell lines derived from parental A253 cells. p53-expressing A253 cells (A253-p53) were also isolated by dilutional cloning. Nuclear p53 protein was identified by immunohistochemistry in A253- p53 cells in a wild-type pattern, and p53 mRNA (2.5 kb) was demonstrated by northern blot. Mutational analysis of the p53 gene in A253-p53 cells revealed no evidence for mutations in exons 5-9. A253-p53 cells could be distinguished from native A253 cells by prolonged doubling times (2-5 fold) and by a marked reduction of [3H]-thymidine uptake. Whereas A253 cells were unresponsive to the growth-inhibitory effects of TGF-β, EGF-stimulated A253-p53 cells responded to TGF-β with markedly reduced DNA synthetic rates. A253-p53 cells cocultured with A253 demonstrated enhanced cell growth and DNA synthesis rates compared to control A253-p53 cells. Finally, A253-p53 cells show reduced expression of c-fos, fibronectin, thrombospondin and parathyroid hormone-related protein (PTHrP) mRNAs. PTHrP measured by RIA in conditioned medium was ≃300 pM for A253 but undetectable for A253-p53. We conclude that the A253 cell line contains a subpopulation of cells which express high levels of 'wild-type-like' p53 protein. This results in dramatic changes in gene expression and a slower-growing phenotype in vitro.

KW - A253

KW - p53

KW - PTHrP

KW - squamous carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0030465431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030465431&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 353

EP - 361

JO - Oncology Research

JF - Oncology Research

SN - 0965-0407

IS - 9

ER -